The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
by taking someone's average glucose from 200 down to 150 that would be considered a huge win in a diabetes trial if you took their glucose from 200 down to 150 and that benefit might show up in their kidneys but if you had to double the amount of insulin you gave them to do that it turns out at the macro vascular level for example heart and brain they don't get any better in fact they might get worse
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.